Literature DB >> 21894215

A patient with a large recurrent pheochromocytoma demonstrating the pitfalls of diagnosis.

Jörg Singer1, Christian A Koch, Woubet Kassahun, Peter Lamesch, Graeme Eisenhofer, Regine Kluge, Thomas Lincke, Matthias Seiwerts, Gudrun Borte, Katrin Schierle, Ralf Paschke.   

Abstract

BACKGROUND: A 59-year-old man presented for a follow-up, 6 years after surgery for a large pheochromocytoma. He had suffered from diabetes mellitus, hypertension and abdominal pain in the right flank region. Previous postoperative follow-up did not reveal tumor recurrence. INVESTIGATION: Measurement of plasma free metanephrine and normetanephrine by high-performance liquid chromatography and radioimmunoassay; 123I-metaiodobenzylguanidine (MIBG) scintigraphy; hybrid 123I-MIBG single-photon emission CT (SPECT)-CT; MRI; testing for plasma norepinephrine and epinephrine; intraoperative ultrasonography; histological staining for chromogranin A and synaptophysin; and postoperative 18F-dihydroxyphenylalanine (DOPA) PET scan. DIAGNOSIS: Recurrent pheochromocytoma. MANAGEMENT: Laparotomy with tumor resection. Reduction of antihypertensive medications. Further follow-up by MRI, hybrid 123I-MIBG SPECT-CT and testing for plasma catecholamines and free metanephrines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21894215     DOI: 10.1038/nrendo.2011.132

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  30 in total

1.  Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma.

Authors:  Birke Bausch; Wiktor Borozdin; Hartmut P H Neumann
Journal:  N Engl J Med       Date:  2006-06-22       Impact factor: 91.245

2.  A logistic regression model for predicting malignant pheochromocytomas.

Authors:  Baohua Gao; Yanxia Sun; Zhongguo Liu; Fanwei Meng; Benkang Shi; Yuqiang Liu; Zhishun Xu
Journal:  J Cancer Res Clin Oncol       Date:  2007-11-13       Impact factor: 4.553

3.  Does tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors?

Authors:  C Pohlink; A Tannapfe; U Eichfeld; F Schmidt; D Führer; R Paschke; C A Koch
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

4.  Analysis of large versus small pheochromocytomas: operative approaches and patient outcomes.

Authors:  S M Wilhelm; R A Prinz; A M Barbu; R P Onders; C C Solorzano
Journal:  Surgery       Date:  2006-09-07       Impact factor: 3.982

5.  Pilot quality assurance programme for plasma metanephrines.

Authors:  Dilo Pillai; Shaw Callen
Journal:  Ann Clin Biochem       Date:  2010-02-09       Impact factor: 2.057

6.  Adrenal cortical tumors, pheochromocytomas and paragangliomas.

Authors:  Ricardo V Lloyd
Journal:  Mod Pathol       Date:  2011-04       Impact factor: 7.842

7.  6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.

Authors:  Helle-Brit Fiebrich; Adrienne H Brouwers; Michiel N Kerstens; Milan E J Pijl; Ido P Kema; Johan R de Jong; Pieter L Jager; Philip H Elsinga; Rudi A J O Dierckx; Jacqueline E van der Wal; Wim J Sluiter; Elisabeth G E de Vries; Thera P Links
Journal:  J Clin Endocrinol Metab       Date:  2009-07-21       Impact factor: 5.958

8.  Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas.

Authors:  Laurence Amar; Eric Baudin; Nelly Burnichon; Séverine Peyrard; Stéphane Silvera; Jérôme Bertherat; Xavier Bertagna; Martin Schlumberger; Xavier Jeunemaitre; Anne-Paule Gimenez-Roqueplo; Pierre-François Plouin
Journal:  J Clin Endocrinol Metab       Date:  2007-07-24       Impact factor: 5.958

Review 9.  New imaging approaches to phaeochromocytomas and paragangliomas.

Authors:  Bas Havekes; Kathryn King; Edwin W Lai; Johannes A Romijn; Eleonora P M Corssmit; Karel Pacak
Journal:  Clin Endocrinol (Oxf)       Date:  2009-06-08       Impact factor: 3.478

10.  Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.

Authors:  Hui Huang; Jame Abraham; Elizabeth Hung; Steven Averbuch; Maria Merino; Seth M Steinberg; Karel Pacak; Tito Fojo
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.921

View more
  3 in total

1.  Retroperitoneal paraganglioma manifesting as paralytic ileus: a case report.

Authors:  Wei-Chen Lin; Horng-Yuan Wang; Chen-Wang Chang; Jiun-Lu Lin; Chung-Hsin Tsai
Journal:  J Med Case Rep       Date:  2012-06-20

2.  Ultrasound imaging in the diagnosis of benign and suspicious adrenal lesions.

Authors:  Jin Fan; Jie Tang; Jiabin Fang; Qiuyang Li; Enhui He; Jia Li; Yanqiu Wang
Journal:  Med Sci Monit       Date:  2014-11-03

Review 3.  Von Hippel-Lindau Disease: Current Challenges and Future Prospects.

Authors:  Sven Gläsker; Evelynn Vergauwen; Christian A Koch; Alexander Kutikov; Alexander O Vortmeyer
Journal:  Onco Targets Ther       Date:  2020-06-16       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.